Updated Direct-to-Consumer Awareness Campaign Available for LINZESS

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. announced today the launch of an updated direct-to-consumer (DTC) awareness campaign for LINZESS® (linaclotide).

Please see full Prescribing Information including Boxed Warning at http://www.frx.com/pi/linzess_pi.pdf. The company has made the television advertisement available on Business Wire’s website and YouTube channel. More information about LINZESS is available at www.linzess.com.

LINZESS® is a trademark owned by Ironwood Pharmaceuticals, Inc. Any other trademarks referred to in this alert are the property of their respective owners. All rights reserved.